The Prosthetic Heart Valve Market is Dominated by Three Leading Companies: Edwards Lifesciences; St. Jude Medical and Medtronic, Inc.: Companiesandmarkets.com

LONDON--(BUSINESS WIRE)--The prosthetic heart valve market is expected to reach a value of $1.3 billion by 2017, according to a new report available from companiesandmarkets.com. Growth is being driven by the global ageing population, increased incidence of obesity and diabetes, as well as improvements in technology and cost reduction.

MORE ON THIS TOPIC